Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk PAH Patients (HYPERION)

Status

Active

DZG

DZL

Start date

03/23/2021

Parameters

Inclusion criteria
  • newly diagnosed PAH at intermediate/high risk
Exclusion criteria
  • prevalent PAH